Bleeding Disorders and Cosmetic Surgery: What Easy Bruising, Heavy Periods, and a Bad Wisdom Tooth Extraction Can Mean, Why Routine Pre-Op Labs Miss Von Willebrand Disease, and How DDAVP, Tranexamic Acid, and a Hematology Plan Make a Breast Reduction or Tummy Tuck Safer

The patient is 31. She would like a breast reduction, and while she is under anesthesia, liposuction of her flanks. She has wanted the reduction since she was a teenager: back pain, bra straps that groove her shoulders, and a sports bra that never quite does its job. On the intake form, in the box that asks about bleeding problems, she wrote "bruise easily, probably nothing." Asked to say more, she mentioned that her periods have always been heavy enough that she takes iron pills, that she bled for two days after her wisdom teeth were removed and had to go back to the oral surgeon, and that her mother "is the same way."

Her pre-operative blood work came back normal: platelet count, PT, and PTT all within range. By the logic of most consultation checklists, she is cleared. She may not be. That combination of heavy periods, a dental extraction that would not stop bleeding, and a mother with the same story is a textbook description of von Willebrand disease, the most common inherited bleeding disorder, and the standard pre-operative panel is very good at missing it.

This piece covers why a bleeding history matters more in cosmetic surgery than patients tend to think, which questions in that history should change the plan, why the usual labs fail to catch the most common disorder, what von Willebrand disease, hemophilia carrier status, and the other inherited disorders actually are, and how a diagnosed bleeding disorder changes the operation, the setting, and the recovery for procedures such as breast reduction, tummy tuck, liposuction, and facelift.

Why a bleeding history matters more in cosmetic surgery than most patients think

The short answer: cosmetic operations create large raw surfaces under skin flaps, where even modest extra bleeding collects as a hematoma that can require a return to the operating room, compromise skin blood supply, and spoil the result, so a mild bleeding tendency that would be a nuisance during a dental cleaning can become a real complication after a breast reduction, tummy tuck, or facelift.

Every operation causes bleeding, and normal clotting stops most of it within minutes. What makes aesthetic surgery different is the anatomy of the wound. A facelift lifts the skin of the cheeks and neck off the underlying tissue across a broad area. A tummy tuck separates the abdominal skin from the muscle wall from the pubic area to the ribs. A breast reduction removes a large volume of tissue and leaves a cavity that the remaining breast must fill. Liposuction passes a cannula through fat in hundreds of tunnels. Each creates a space where blood can pool if small vessels continue to ooze after the incisions are closed.

When blood collects in that space, it forms a hematoma. A small one may resorb on its own. A larger one stretches the overlying skin, raises pressure on the flap, and can cut off the blood supply that the skin depends on, which is why hematoma and skin necrosis after facelift and tummy tuck are discussed together. An expanding hematoma usually means a return to the operating room to evacuate the clot and find the bleeding vessel. Even when that goes well, the patient faces more bruising, more swelling, a longer recovery, and a higher chance of firmness, contour irregularity, or seroma after plastic surgery in the weeks that follow.

Hematoma rates for healthy patients are already meaningful. It is the most common serious early complication of facelift, as described in the piece on hematoma after facelift, and occurs in a few percent of breast reductions, augmentations, and abdominoplasties. Those rates come from patients with normal clotting. A patient with an undiagnosed bleeding disorder starts from a higher baseline, and because the operation is elective, nothing about the timing prevents finding out first.

Two features of aesthetic surgery make this more pressing, not less. The first is that many operations are combined, as in the patient above, which lengthens the anesthetic and multiplies the raw surface. The second is that many are performed in office-based surgical suites, where the laboratory tests and clotting factor products needed to manage a bleeding disorder may not be available on the day. The piece on outpatient facility accreditation covers what those suites are and are not set up to handle.

The bleeding history that should change the plan, and why routine labs miss it

The short answer: a careful history is more useful than any routine blood test for finding a mild bleeding disorder, and the standard pre-operative panel of platelet count, PT, and PTT is often completely normal in von Willebrand disease, so a patient with heavy periods, prolonged bleeding after dental work or earlier surgery, or a family history of the same should have specific testing before elective surgery.

Most people who say they bruise easily do not have a bleeding disorder. Bruising is common, and it increases with age, sun damage, thin skin, and medications. The aim of the history is to separate ordinary bruising from a pattern that suggests something more. Hematologists use structured questionnaires for this, the most widely cited being the bleeding assessment tool of the International Society on Thrombosis and Haemostasis, which scores each type of bleeding by severity. A surgeon does not need to administer the full tool, but the questions that carry the most weight are worth knowing:

• Bleeding after dental extractions, particularly bleeding that lasted more than a few hours, restarted the next day, or required a return visit, packing, or stitches.
• Bleeding after previous surgery, including tonsillectomy in childhood, or a prior operation where the patient was told she bled more than expected or needed a transfusion.
• Heavy menstrual bleeding, especially since the first periods, and especially if it has caused iron deficiency or required treatment.
• Bleeding after childbirth, including a postpartum hemorrhage that needed a transfusion or procedure.
• Nosebleeds that last longer than about ten minutes, occur without an obvious cause, or have needed cautery or packing.
• Bruises larger than a few centimeters that appear without remembered injury, or that form raised lumps.
• Gum bleeding with ordinary brushing, or prolonged bleeding from small cuts.
• A family history of any of the above, or of a diagnosed bleeding disorder, particularly in a parent or sibling. In hemophilia, the family history may show up as bleeding in male relatives on the mother's side.

Heavy periods deserve particular attention, because they are the single most common symptom of von Willebrand disease in women and are routinely treated as normal. The Centers for Disease Control and Prevention describes heavy menstrual bleeding as needing to change a pad or tampon every one to two hours, passing clots the size of a quarter or larger, or periods lasting longer than seven days. Studies of women with heavy menstrual bleeding have found an underlying bleeding disorder in a meaningful minority, with figures for von Willebrand disease alone commonly cited in the range of 5 to 20 percent. The American College of Obstetricians and Gynecologists recommends that adolescents with heavy menstrual bleeding be evaluated for a bleeding disorder. Many adults with heavy periods were never evaluated, and a cosmetic consultation may be the first time anyone has asked.

Heavy periods matter for a second reason as well: they cause iron deficiency, and iron deficiency causes anemia. A patient who starts a breast reduction or tummy tuck with a low hemoglobin has less reserve for whatever blood she loses, as the piece on anemia and blood loss before and after cosmetic surgery explains. That is fixable before surgery, often with intravenous iron when oral iron has not worked.

Why routine labs miss it. The tests on a standard pre-operative panel, discussed in the piece on preoperative testing before cosmetic surgery, are a platelet count, the prothrombin time (PT, or INR), and the activated partial thromboplastin time (PTT or aPTT). These are good at detecting low platelets, the effect of warfarin, liver disease, and significant deficiencies of most clotting factors. They are poor at detecting von Willebrand disease. Von Willebrand factor helps platelets stick to the injured vessel wall, and it carries and protects factor VIII. In the most common form of the disease, levels are only moderately reduced, the platelet count is normal, and the PTT is normal unless factor VIII has fallen far enough to prolong it, which in mild disease it usually has not. A normal panel in a patient with the history above is not reassurance. It is a test that was not designed to answer the question.

The older bleeding time test has been largely abandoned because it is unreliable, and the platelet function analyzer used in some hospitals is not sensitive enough to rule out mild von Willebrand disease. The specific tests are a von Willebrand factor antigen level, a von Willebrand factor activity level, and a factor VIII activity level, usually ordered together and interpreted by a hematologist. If those are abnormal, further tests determine the type.

There is a further trap. Von Willebrand factor levels rise with stress, exercise, inflammation, pregnancy, and estrogen, including estrogen-containing birth control pills, and are naturally about a quarter lower in people with blood type O. A patient tested after a stressful blood draw, while taking a combined oral contraceptive, may have a normal result that does not reflect her usual level. Hematologists often repeat the tests when the history is convincing and the first result is borderline.

"A normal PTT in a woman with heavy periods and a dental extraction that bled for two days is not a clearance. It is a test that was never designed to answer the question being asked."

Von Willebrand disease, hemophilia carriers, and the other disorders worth knowing

The short answer: von Willebrand disease is the most common inherited bleeding disorder and is usually the mild type 1 form, women who carry the hemophilia gene can have low factor levels and bleed more than expected, factor XI deficiency is relatively common in people of Ashkenazi Jewish ancestry, mild platelet function disorders are frequent and hard to diagnose, and several acquired conditions and medications can mimic all of them.

Von Willebrand disease. The CDC estimates that up to about 1 percent of the population has von Willebrand disease, although only a fraction have symptoms significant enough to come to medical attention, and many of those are never diagnosed. It affects men and women equally, but women are more often symptomatic because of menstruation and childbirth. The disease comes in three main types. Type 1, by far the most common, is a partial reduction in the amount of normal von Willebrand factor. Type 2 is a group of qualitative defects in which the factor is present but works abnormally, with subtypes labeled 2A, 2B, 2M, and 2N. Type 3, which is rare, is a near-complete absence of the factor and produces severe bleeding. The 2021 guidelines on von Willebrand disease diagnosis from the American Society of Hematology, the International Society on Thrombosis and Haemostasis, the National Hemophilia Foundation, and the World Federation of Hemophilia simplified the diagnostic thresholds: a von Willebrand factor level below 30 percent of normal confirms type 1 disease regardless of bleeding history, and a level between 30 and 50 percent confirms it in a patient with abnormal bleeding. That means a patient with levels in the gray zone and a convincing history is treated as having the disease, which is exactly the group most likely to be missed.

Hemophilia carriers. Hemophilia A and B, deficiencies of factor VIII and factor IX, are inherited on the X chromosome, so they mainly affect men. Women who carry the gene were long assumed to be unaffected. They are not always. A sizable minority of carriers have factor levels low enough to cause bleeding after surgery, childbirth, and dental work, and some carriers with normal levels still bleed more than expected. Since 2021, the International Society on Thrombosis and Haemostasis has classified women and girls with factor levels below 40 percent of normal as having hemophilia rather than being simply carriers. Any woman with a father, brother, son, or maternal uncle or grandfather with hemophilia should have her factor level checked before elective surgery, even if she has never had a bleeding problem. Hemophilia B is not helped by desmopressin, which is one reason the exact diagnosis matters.

Factor XI deficiency. Sometimes called hemophilia C, this deficiency is rare in most populations but relatively common among people of Ashkenazi Jewish ancestry, in whom carrier rates of several percent have been reported. Its awkward feature is that bleeding risk does not track neatly with factor level: some patients with moderate deficiency bleed heavily after surgery, others with low levels do not. Bleeding tends to occur in tissues with high fibrinolytic activity, such as the mouth, nose, and urinary tract. The PTT is often prolonged in significant deficiency, but not always in mild cases.

Platelet function disorders. A group of inherited conditions in which the platelet count is normal but platelets do not aggregate or release their contents properly. Severe forms such as Glanzmann thrombasthenia are rare and usually diagnosed in childhood. Milder disorders of platelet secretion and signaling are probably common, produce a bleeding pattern similar to mild von Willebrand disease, and require specialized platelet aggregation testing that many laboratories do not perform.

Connective tissue disorders. Easy bruising and poor wound healing are features of Ehlers-Danlos syndromes, not because clotting is abnormal but because blood vessels and skin are fragile. The piece on Ehlers-Danlos syndrome and cosmetic surgery covers that separate set of risks. Hypermobility and a bleeding disorder can coexist, and a patient with both needs both evaluated.

Acquired causes that mimic an inherited disorder. Not every bleeding tendency is lifelong. Liver disease reduces production of clotting factors, as described in the piece on fatty liver disease and cosmetic surgery. Kidney failure impairs platelet function, a point covered in the piece on chronic kidney disease and dialysis before cosmetic surgery. An acquired form of von Willebrand syndrome can arise with severe aortic valve stenosis, an underactive thyroid, some blood and immune disorders, and the seizure medication valproate, which is one of the drug issues raised in the piece on epilepsy and cosmetic surgery. And medications and supplements, discussed below, are the commonest cause of all.

How a diagnosed bleeding disorder changes the operation

The short answer: most patients with mild von Willebrand disease, hemophilia carrier status, or factor XI deficiency can have elective cosmetic surgery safely, but only with a written plan from a hematologist that specifies the drugs, doses, and laboratory checks, which usually means desmopressin or factor concentrate before surgery, tranexamic acid around it, a facility that can run the necessary tests and supply the products, and a more careful approach to clot prevention.

A bleeding disorder is rarely a reason to refuse elective surgery. It is a reason to plan it. The planning belongs to the hematologist and the surgeon together, and it should be finished, in writing, before the date is booked.

Desmopressin. Desmopressin, often called DDAVP, is a synthetic hormone that releases stored von Willebrand factor and factor VIII from the lining of blood vessels, raising their levels two to several times within about an hour. It works well in most people with type 1 von Willebrand disease and in many hemophilia A carriers. It does not work in type 3 disease, is usually avoided in type 2B because it can lower the platelet count, and does nothing for hemophilia B or factor XI deficiency. Because responses vary, the 2021 guidelines recommend a desmopressin trial before relying on it: the drug is given on a separate day and levels are measured afterward to confirm the patient responds. Desmopressin has two side effects that matter around surgery. It causes the body to retain water, which can lower blood sodium to dangerous levels if the patient drinks or receives too much fluid, so fluid intake is restricted for about a day after each dose. And repeated doses lose effect over a few days as the stores are depleted. That makes it well suited to a single operation with a short recovery and less suited to an extended combined procedure that may need several days of cover.

Factor concentrates. When desmopressin does not work or is unsuitable, the hematologist will prescribe concentrates of von Willebrand factor, factor VIII, or factor IX, which are infused before surgery and sometimes for several days afterward. The 2021 guidelines suggest targeting both von Willebrand factor and factor VIII activity levels of at least 50 percent of normal for at least three days after major surgery. That requires measuring levels after surgery, which in turn requires a laboratory that can perform the tests promptly. Factor XI deficiency may be managed with tranexamic acid alone for minor procedures or with plasma or factor XI concentrate for major ones, depending on the patient's level and bleeding history.

Tranexamic acid. Tranexamic acid blocks the breakdown of clots once they have formed. It is widely used in cosmetic surgery even in patients without bleeding disorders, as described in the piece on tranexamic acid in cosmetic surgery, and for patients with mild bleeding disorders it is often the cornerstone of the plan, given intravenously at surgery and by mouth for several days afterward. It is particularly effective for bleeding from the mouth and nose, which matters for procedures inside the mouth and for rhinoplasty. The 2021 guidelines suggest tranexamic acid alone may be enough for minor procedures in type 1 von Willebrand disease.

The setting. A patient whose plan involves factor concentrates and postoperative level checks generally belongs in a hospital or a surgical facility with direct access to a hematology service and a laboratory that can measure factor levels the same day. A patient whose plan is tranexamic acid alone, for a small procedure, may be well cared for in an accredited office suite. The decision should follow from the hematology plan, not from scheduling convenience, and it is a strong argument against combining many procedures in one long session, and against surgery abroad, where the surgeon may not have the products or the follow-up laboratory work, and the hematologist is thousands of miles away.

Procedure by procedure. The disorder interacts differently with each operation:

• Breast reduction removes a large volume of tissue and leaves extensive raw surfaces. It is a procedure where a hematology plan is clearly warranted. Many surgeons use drains in these patients even if they would otherwise forgo them, as discussed in the piece on surgical drains after plastic surgery. The general risks of the operation itself are covered in the piece on breast reduction surgery.
• Tummy tuck creates one of the largest flap spaces in aesthetic surgery. Progressive tension sutures, which close the space between skin and muscle, may reduce dead space where blood collects, as described in the piece on drainless tummy tuck with progressive tension sutures, but they do not substitute for correcting the clotting problem.
• Liposuction relies on tumescent fluid containing dilute epinephrine to constrict blood vessels, which dramatically reduced blood loss compared with older techniques. Patients with bleeding disorders still bruise more extensively, and large-volume liposuction over several areas carries real blood loss. The piece on lidocaine toxicity in tumescent liposuction describes the other limits on how much fluid can be used.
• Facelift and neck lift already carry the highest hematoma risk of any common cosmetic operation, and blood pressure control in the hours after surgery is a major part of prevention, as covered in the piece on high blood pressure before cosmetic surgery. A bleeding disorder adds to that risk, and the plan should be correspondingly cautious.
• Injectables and minor procedures. Fillers and neurotoxin injections cause more bruising in patients with bleeding disorders but are rarely dangerous. Patients with severe disorders should discuss them with their hematologist, and those on factor replacement may time injections to follow a dose.

Clot prevention, the awkward part. Patients with bleeding disorders are not protected from blood clots. A long operation, general anesthesia, reduced mobility, and estrogen all raise clot risk in anyone, and the piece on blood clots after plastic surgery explains how surgeons score that risk. The usual preventive drug, low-dose injectable blood thinner, is used more cautiously in a patient who also has a bleeding disorder and is receiving drugs that boost clotting. The answer is usually more reliance on early walking and compression devices, careful judgment about chemical prophylaxis, and a decision made jointly by the surgeon and the hematologist rather than by the default protocol.

The birth control problem. Women with von Willebrand disease are often treated with combined estrogen-containing birth control pills, which raise von Willebrand factor levels and lighten periods. Surgeons routinely ask patients to stop those pills for several weeks before major surgery because estrogen raises clot risk, as described in the piece on birth control before cosmetic surgery. For a woman with von Willebrand disease, stopping the pill can bring back heavy periods, lower her factor levels, and leave her anemic at exactly the wrong moment. The solution varies, sometimes switching to a progestin-only method or a hormonal IUD in advance, but it needs to be discussed among the surgeon, the hematologist, and the gynecologist well before the operation, not on the morning of it.

Recovery, hematoma warning signs, and what makes bleeding worse

The short answer: patients with bleeding disorders need to avoid the medications and supplements that impair clotting, follow the hematologist's schedule for tranexamic acid and any repeat doses exactly, and know the signs of an expanding hematoma, which include rapidly increasing swelling on one side, new firmness, tightness, and pain out of proportion to the rest of the recovery, and which require a call to the surgeon immediately rather than at the next appointment.

Medications and supplements. The commonest cause of abnormal bleeding after surgery is not an inherited disorder but something the patient took. Aspirin and NSAIDs such as ibuprofen and naproxen impair platelet function, and the piece on ibuprofen and NSAIDs after cosmetic surgery explains the debate about their use in patients with normal clotting. In a patient with von Willebrand disease or a platelet disorder, that debate is mostly settled: they are usually avoided, and acetaminophen and other approaches take their place, as described in the piece on opioid-sparing recovery. Prescription blood thinners, discussed in the piece on blood thinners before cosmetic surgery, raise their own coordination problems. SSRI antidepressants modestly impair platelet function, as the piece on SSRI antidepressants and surgery bleeding explains, and are usually continued, but they add to the picture in a patient who already bleeds. Fish oil, vitamin E, ginkgo, garlic supplements, turmeric, and several other products have antiplatelet effects, and the piece on supplements to stop before surgery lists the usual offenders. Patients with bleeding disorders should give their full supplement list to both surgeon and hematologist, because some of these are taken without much thought.

Bruising remedies. Arnica and bromelain are popular with cosmetic surgery patients, and the evidence for them is weak, as discussed in the piece on arnica and bromelain for bruising after surgery. Bromelain in particular has mild antiplatelet effects and is a poor choice for a patient with a bleeding disorder. More bruising than average is expected, and the swelling timeline after plastic surgery may run longer.

Warning signs of a hematoma. Most hematomas declare themselves in the first 24 to 48 hours, although delayed hematomas can occur days later, especially when a patient becomes more active or her blood pressure spikes. The signs that warrant an immediate call to the surgeon:

• Swelling that is rapidly increasing, especially if one side is clearly larger than the other.
• A tense, firm, or tight area that feels different from the rest of the surgical site.
• Pain that is worsening rather than settling, or that is much greater on one side.
• Drain output that suddenly increases or turns bright red, if drains are in place.
• Blood soaking through dressings or leaking from incisions.
• Lightheadedness, a rapid heartbeat, or fainting, which can signal significant blood loss.

Patients with bleeding disorders should have someone with them for at least the first night, as described in the piece on the first 72 hours and a recovery caregiver, and should know who to call at night and on weekends. The hematologist should be informed of any bleeding complication, because the treatment of a hematoma in a patient with a bleeding disorder usually includes additional factor replacement or desmopressin, not just evacuation.

Before the next operation. A patient who discovers a bleeding disorder through cosmetic surgery planning has learned something that matters for every future dental extraction, childbirth, and operation. She should carry a letter from the hematologist describing the diagnosis and the plan that worked, and her relatives may want testing. A second consultation is reasonable for any patient whose surgeon seems dismissive of a convincing bleeding history, or who proposes a long combined operation in an office suite without a hematology plan.

The honest summary

Most people who bruise easily do not have a bleeding disorder. But a pattern of heavy periods, prolonged bleeding after dental extractions, surgery, or childbirth, frequent long nosebleeds, and a family member with the same story points toward one, and the most common, von Willebrand disease, affects up to about 1 percent of people and is usually undiagnosed. Cosmetic surgery matters here because it creates large raw spaces under skin flaps, where extra bleeding becomes a hematoma that can require a return to the operating room and harm the result.

The standard pre-operative labs, platelet count, PT, and PTT, are often normal in mild von Willebrand disease. A convincing history calls for specific testing of von Willebrand factor and factor VIII, interpreted by a hematologist, and repeated if the first result is borderline, because stress, estrogen, and blood type all affect the numbers. Women with a family history of hemophilia should have their own factor levels checked before surgery. Factor XI deficiency is worth considering in patients of Ashkenazi Jewish ancestry, and mild platelet function disorders are common and hard to diagnose.

A diagnosed disorder is rarely a reason to avoid surgery. It is a reason to have a written plan: a desmopressin trial or factor concentrates, tranexamic acid around the operation, a facility that can measure factor levels and supply products, a cautious approach to clot prevention, coordination about birth control, avoidance of NSAIDs and antiplatelet supplements, and a clear plan for what happens if a hematoma develops. Heavy periods also cause iron deficiency, which should be corrected before surgery.

The patient at the top of this piece did not have her surgery on the first date offered. Her surgeon referred her to a hematologist, whose testing showed a von Willebrand factor level of 38 percent, in the range that, with her history, confirms type 1 disease. A desmopressin trial showed a good response. She had an iron infusion to correct her anemia, switched from her birth control pill to a hormonal IUD three months before surgery, and had the breast reduction in a hospital with desmopressin before the operation and tranexamic acid for a week afterward. The flank liposuction was postponed to a separate, shorter session. Her recovery was uneventful. Her mother was tested the following month and had the same diagnosis, at 63, after a lifetime of being told she simply bruised easily.